SGM
RETA

Skye Global Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Skye Global Management’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,500
Closed -$920K – 79
2021
Q2 		$920K Buy
+6,500
New +$920K 0.02% 49